Cargando…

Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease

BACKGROUND: Previous studies indicate a role of P2X(7 )receptors in processes that lead to neuronal death. The main objective of our study was to examine whether genetic deletion or pharmacological blockade of P2X(7 )receptors influenced dopaminergic cell death in various models of Parkinson's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hracskó, Zsuzsanna, Baranyi, Mária, Csölle, Cecilia, Gölöncsér, Flóra, Madarász, Emilia, Kittel, Ágnes, Sperlágh, Beáta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113297/ https://www.ncbi.nlm.nih.gov/pubmed/21542899 http://dx.doi.org/10.1186/1750-1326-6-28

Ejemplares similares

The double-faced role of P2X(7) receptors in toxin-induced animal models of Parkinson’s disease
por: Sperlágh, Beáta, et al.
Publicado: (2011)

The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice
por: Csölle, Cecilia, et al.
Publicado: (2013)

Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors
por: Csölle, Cecilia, et al.
Publicado: (2013)

Learned helplessness paradigm in P2xr7 wild type and knock out mice and its effect on synapses in the dentate gyrus
por: Otrokocsi, Lilla, et al.
Publicado: (2015)

Effect of genetic deletion and pharmacological antagonism of P2X7 receptors in a mouse animal model of migraine
por: Gölöncsér, Flóra, et al.
Publicado: (2014)

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2016)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

The antidepressant effect of short- and long-term zinc exposition is partly mediated by P2X7 receptors in male mice
por: Iring-Varga, Bernadett, et al.
Publicado: (2023)

The role of P2X(7 )ATP receptors in the nervous system: potential implications in inflammatory and depression-like diseases
por: Csölle, Cecília, et al.
Publicado: (2009)

Central P2Y(12) receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents
por: Horváth, Gergely, et al.
Publicado: (2014)

P2 receptor-mediated modulation of neurotransmitter release—an update
por: Sperlágh, Beáta, et al.
Publicado: (2007)

Investigation of P2X7R involvement in maternal poly(i:C) exposure evoked autistic features in mice
por: Horváth, Gergely, et al.
Publicado: (2015)

Regulation of Hippocampal 5-HT Release by P2X7 Receptors in Response to Optogenetic Stimulation of Median Raphe Terminals of Mice
por: Gölöncsér, Flóra, et al.
Publicado: (2017)

The effects of optical, electrical and chemical stimulation on serotonin release from median raphe and hippocampus of mice
por: Goloncser, Flora, et al.
Publicado: (2015)

Modulation of dopaminergic neurotransmission in rat striatum upon in vitro and in vivo diclofenac treatment1
por: Milusheva, Elisaveta, et al.
Publicado: (2008)

P2X7 Receptors Drive Spine Synapse Plasticity in the Learned Helplessness Model of Depression
por: Otrokocsi, Lilla, et al.
Publicado: (2017)

The role of P2X7 receptors in a rodent PCP-induced schizophrenia model
por: Koványi, Bence, et al.
Publicado: (2016)

Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: a systematic experiment literatures review
por: Wang, Xin-Shi, et al.
Publicado: (2017)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Median raphe region stimulation alone generates remote, but not recent fear memory traces
por: Balázsfi, Diána G., et al.
Publicado: (2017)

Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
por: Tóth, Adrián, et al.
Publicado: (2019)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
por: Giuliano, Claudio, et al.
Publicado: (2021)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Elevated Serum Purine Levels in Schizophrenia: A Reverse Translational Study to Identify Novel Inflammatory Biomarkers
por: Kristóf, Zsüliet, et al.
Publicado: (2022)

The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel
por: Stephan, Gabriele, et al.
Publicado: (2018)

Author Correction: The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel
por: Stephan, Gabriele, et al.
Publicado: (2018)

GPR3 Receptor, a Novel Actor in the Emotional-Like Responses
por: Valverde, Olga, et al.
Publicado: (2009)

STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs
por: Chiriac, Mircea T., et al.
Publicado: (2023)

GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson’s disease
por: Maitra, Urmila, et al.
Publicado: (2021)

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
por: Bhavani, Keserla, et al.
Publicado: (2023)

Dual Role of the P2X7 Receptor in Dendritic Outgrowth during Physiological and Pathological Brain Development
por: Mut-Arbona, Paula, et al.
Publicado: (2023)

Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
por: Wąsik, Agnieszka, et al.
Publicado: (2015)

CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
por: Saraiva, Cláudia, et al.
Publicado: (2023)

Lack of Neuroprotective Effect of Celastrol Under Conditions of Proteasome Inhibition by Lactacystin in In Vitro and In Vivo Studies: Implications for Parkinson’s Disease
por: Konieczny, Jolanta, et al.
Publicado: (2014)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Roles Played by the Na(+)/Ca(2+) Exchanger and Hypothermia in the Prevention of Ischemia-Induced Carrier-Mediated Efflux of Catecholamines into the Extracellular Space: Implications for Stroke Therapy
por: Lakatos, M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d0vbrqefvtqhbo9kt41517m5r0